LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
  • AstraZeneca PLC (LSE: AZN) Latest News

    Investing Videos

    Lessons From The AstraZeneca plc/Pfizer Kerfuffle

    VIDEO: One Fool puts the spotlight on AstraZeneca plc (LON:AZN).

    Read more »

    Investing Articles

    The AstraZeneca plc Takeover Could Still Be On

    Major shareholders are urging AstraZenenca plc (LON: AZN) to reconsider Pfizer's offer.

    Read more »

    Investing Articles

    AstraZeneca plc: Is It Still A Buy Now That Pfizer Has Gone?

    Should you buy what Pfizer couldn't? Harvey Jones examines the case for AstraZeneca plc (LON: AZN).

    Read more »

    Investing Articles

    All Is Not Lost: AstraZeneca plc Has Less Than 48hrs To Cut A Deal With Pfizer

    AstraZeneca plc (LON: AZN) has until Monday to negotiate a deal with Pfizer.

    Read more »

    Investing Articles

    AstraZeneca plc Was Right To Shun Pfizer

    Pfizer's bid for AstraZeneca plc (LON: AZN) was not in the long-term interests of the business.

    Read more »

    Investing Articles

    Who Can Pfizer Inc. Afford?

    Are Bristol-Myers Squibb Co (NYSE: BMY) or Shire PLC (LON:SHP) on Pfizer Inc. (NYSE:PFE)'s shopping list?

    Read more »

    Investing Articles

    Why Do People Care If One Company Buys Another?

    Who cares if Pfizer wants to buy AstraZeneca plc (LON:AZN)? We all do, says Harvey Jones

    Read more »

    Investing Articles

    AstraZeneca plc: Time To Cash In?

    There are several reasons why Astra (LON:AZN) investors may want to cash in now, argues Alessandro Pasetti

    Read more »

    Investing Articles

    What Should AstraZeneca plc Shareholders Learn From Failed Pfizer Bid?

    AstraZeneca plc (LON:AZN) shareholders should be happy, despite Pfizer's failure, says Roland Head.

    Read more »

    Investing Articles

    How Much Lower Can AstraZeneca plc Go?

    Will AstraZeneca plc's (LON:AZN) shares continue to fall?

    Read more »

    Company Comment

    Lessons From The Great Investors… On Coca-Cola And AstraZeneca plc

    AstraZeneca plc (LON: AZN) and Coca-Cola are the quintessential investments of two of the all-time greats.

    Read more »

    Company Comment

    What You Need To Know About AstraZeneca plc Rejecting Pfizer’s Final Offer

    AstraZeneca plc (LON: AZN) will live on as a standalone entity with ambitious revenue targets and a buzzing drugs pipeline.

    Read more »